Sporotrichosis: The Story of an Endemic Region in Peru over 28 Years (1985 to 2012)
Open Access
- 1 June 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (6), e0127924
- https://doi.org/10.1371/journal.pone.0127924
Abstract
Abancay province is a long-standing geographical focus of sporotrichosis in the south central highlands of Peru. Therefore, we examined the features of 36 newly identified cases of sporotrichosis from two hospital centers in Abancay province. We also performed a literature review of studies conducted in this endemic geographical focus over a period of 28 years (1998 to 2012), and analyzed the demographic, clinical and epidemiological features of sporotrichosis in the cases reported in these studies. We examined the features of 36 new cases of sporotrichosis identified from two hospital centers in Abancay. Furthermore, we searched for relevant studies of cases of sporotrichosis in the endemic region using healthcare databases and literature sources. We analyzed a detailed subset of data on cases collected in Abancay, neighboring provinces, and other regions of Peru. A total of nine studies were identified, with 1467 cases included in the final analysis. We also analyzed 36 new cases found in the two hospital centers. Therefore, the combined total of cases analyzed was 1503. Of this total, 58% were male, and approximately 62% were aged ≤14 years. As expected, most cases were from Abancay province (88%), although 12% were from neighboring provinces and other regions of Peru. The lymphocutaneous form (939 cases) was the commonest. The face was the most commonly affected region (647 cases). A total of 1224 patients (81.4%) received treatment: 95.8% received potassium iodide, 2.6% ketoconazole and 1.6% itraconazole. The overall success rates were 60.7% with potassium iodide, 32.2% with ketoconazole and 85% with itraconazole. The epidemic of sporotrichosis has been occurring for three decades in the province of Abancay in Peru. This mycosis affects primarily the pediatric population, with predominantly the lymphocutaneous form in the facial region. Although treatment with potassium iodide is safe and effective, response and adherence to treatment are influenced by its duration, cost, accessibility, and side effects.This publication has 21 references indexed in Scilit:
- Sporotrichosis in Sub-Himalayan IndiaPLoS Neglected Tropical Diseases, 2012
- Treatment of Cutaneous Sporotrichosis With Itraconazole--Study of 645 PatientsClinical Infectious Diseases, 2011
- Zoonotic Sporotrichosis in Rio de Janeiro, Brazil: A Protracted Epidemic yet to Be CurbedClinical Infectious Diseases, 2010
- Genetic Determinants of Antibiotic Resistance in DiarrheagenicKlebsiella PneumoniaeSubspeciesozaenae:An Emerging Enteropathogen in SenegalClinical Infectious Diseases, 2010
- Sporothrix brasiliensis,S. globosa, andS. mexicana, Three NewSporothrixSpecies of Clinical InterestJournal of Clinical Microbiology, 2007
- Sporotrichosis with widespread cutaneous lesions: report of 24 cases related to transmission by domestic cats in Rio de Janeiro, BrazilInternational Journal of Dermatology, 2003
- Population‐Based Surveillance and a Case‐Control Study of Risk Factors for Endemic Lymphocutaneous Sporotrichosis in PeruClinical Infectious Diseases, 2003
- Sporotrichosis in Peru: Description of an Area of HyperendemicityClinical Infectious Diseases, 2000
- Treatment of cutaneous sporotrichosis with one daily dose of potassium iodideThe Pediatric Infectious Disease Journal, 1996